Lindsay Piraino, Danielle L. Perry, Ryan Weitzel, Sahar Mokhtari, Sierra K. Kucko, Timothy J. Keenan, Anthony W. Wren
{"title":"Mimicking the Architecture and Dissolution Chemistry of Cancellous Bone Tissue to Optimize the Biocompatibility of Bioactive Scaffolds","authors":"Lindsay Piraino, Danielle L. Perry, Ryan Weitzel, Sahar Mokhtari, Sierra K. Kucko, Timothy J. Keenan, Anthony W. Wren","doi":"10.1002/jbm.b.35497","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Synthesis of mechanically stable porous scaffolds with an architecture analogous to cancellous bone tissue poses significant challenges to bioactive glass (BG) based scaffolds. This is primarily due to densification and crystallization of the BG's during heat treatment. This study presents a modified BG series (42SiO<sub>2</sub>—<i>x</i>TiO<sub>2</sub>—24Na<sub>2</sub>O—21CaO—13P<sub>2</sub>O<sub>5</sub>, where <i>x</i> = 8 and 16 TiO<sub>2</sub>). TiO<sub>2</sub> replaced the SiO<sub>2</sub> concentration in the glass and was incorporated due to its biocompatibility and influence on glass structure. Material characterization determined that TiO<sub>2</sub> did not induce crystallization within the glass but did increase the glass transition temperature (<i>T</i><sub><i>g</i></sub>) from 520°C to 600°C thereby indicating a more stable network connectivity. Scaffolds were synthesized using the foam replication method, resulting in scaffolds with a pore size of approximately 500 μm with the <i>BG-4</i> composition (30SiO<sub>2</sub>—12TiO<sub>2</sub>—24Na<sub>2</sub>O—21CaO—13P<sub>2</sub>O<sub>5</sub>) retaining its amorphous character post-heat treatment. Scaffold ion release was monitored over 5–60 days in simulated body fluid (SBF). Si<sup>4+</sup> release was found to decrease, while Ca<sup>2+</sup> levels increased in SBF as TiO<sub>2</sub> replaced SiO<sub>2</sub> within the glass series. Cytocompatibility studies revealed that MC3T3 Osteoblast cells proliferated on the <i>BG-4</i> scaffold surface and at its interface within culture media, and cell numbers were not significantly reduced.</p>\n </div>","PeriodicalId":15269,"journal":{"name":"Journal of biomedical materials research. Part B, Applied biomaterials","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of biomedical materials research. Part B, Applied biomaterials","FirstCategoryId":"5","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jbm.b.35497","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Synthesis of mechanically stable porous scaffolds with an architecture analogous to cancellous bone tissue poses significant challenges to bioactive glass (BG) based scaffolds. This is primarily due to densification and crystallization of the BG's during heat treatment. This study presents a modified BG series (42SiO2—xTiO2—24Na2O—21CaO—13P2O5, where x = 8 and 16 TiO2). TiO2 replaced the SiO2 concentration in the glass and was incorporated due to its biocompatibility and influence on glass structure. Material characterization determined that TiO2 did not induce crystallization within the glass but did increase the glass transition temperature (Tg) from 520°C to 600°C thereby indicating a more stable network connectivity. Scaffolds were synthesized using the foam replication method, resulting in scaffolds with a pore size of approximately 500 μm with the BG-4 composition (30SiO2—12TiO2—24Na2O—21CaO—13P2O5) retaining its amorphous character post-heat treatment. Scaffold ion release was monitored over 5–60 days in simulated body fluid (SBF). Si4+ release was found to decrease, while Ca2+ levels increased in SBF as TiO2 replaced SiO2 within the glass series. Cytocompatibility studies revealed that MC3T3 Osteoblast cells proliferated on the BG-4 scaffold surface and at its interface within culture media, and cell numbers were not significantly reduced.
期刊介绍:
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is a highly interdisciplinary peer-reviewed journal serving the needs of biomaterials professionals who design, develop, produce and apply biomaterials and medical devices. It has the common focus of biomaterials applied to the human body and covers all disciplines where medical devices are used. Papers are published on biomaterials related to medical device development and manufacture, degradation in the body, nano- and biomimetic- biomaterials interactions, mechanics of biomaterials, implant retrieval and analysis, tissue-biomaterial surface interactions, wound healing, infection, drug delivery, standards and regulation of devices, animal and pre-clinical studies of biomaterials and medical devices, and tissue-biopolymer-material combination products. Manuscripts are published in one of six formats:
• original research reports
• short research and development reports
• scientific reviews
• current concepts articles
• special reports
• editorials
Journal of Biomedical Materials Research – Part B: Applied Biomaterials is an official journal of the Society for Biomaterials, Japanese Society for Biomaterials, the Australasian Society for Biomaterials, and the Korean Society for Biomaterials. Manuscripts from all countries are invited but must be in English. Authors are not required to be members of the affiliated Societies, but members of these societies are encouraged to submit their work to the journal for consideration.